APO Research
Talk to an analyst

APO RESEARCH · REPORT

T Cell Specific Surface Glycoprotein CD28

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global T Cell Specific Surface Glycoprotein CD28 Industry Growth and Trends Forecast to 2032

19 December 202590 pages

Choose your research edition.

Industry ResearchT Cell Specific Surface Glycoprotein CD28 Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal T Cell Specific Surface Glycoprotein CD28 Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal T Cell Specific Surface Glycoprotein CD28 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal T Cell Specific Surface Glycoprotein CD28 Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal T Cell Specific Surface Glycoprotein CD28 Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global T Cell Specific Surface Glycoprotein CD28 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for T Cell Specific Surface Glycoprotein CD28 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for T Cell Specific Surface Glycoprotein CD28 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for T Cell Specific Surface Glycoprotein CD28 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of T Cell Specific Surface Glycoprotein CD28 include Johnson & Johnson, TheraMAB LLC, Five Prime Therapeutics Inc, Bristol-Myers Squibb Co and Atox Bio Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global T Cell Specific Surface Glycoprotein CD28 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The T Cell Specific Surface Glycoprotein CD28 market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global T Cell Specific Surface Glycoprotein CD28 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to T Cell Specific Surface Glycoprotein CD28.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global T Cell Specific Surface Glycoprotein CD28 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

T Cell Specific Surface Glycoprotein CD28 Market by Company

Johnson & Johnson

TheraMAB LLC

Five Prime Therapeutics Inc

Bristol-Myers Squibb Co

Atox Bio Ltd

T Cell Specific Surface Glycoprotein CD28 Segment by Type

Lulizumab Pegol

FR-104

FPT-155

Others

T Cell Specific Surface Glycoprotein CD28 Segment by Application

Plaque Psoriasis

Acute Renal Failure(ARF)

Solid Tumor

Others

T Cell Specific Surface Glycoprotein CD28 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global T Cell Specific Surface Glycoprotein CD28 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of T Cell Specific Surface Glycoprotein CD28 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of T Cell Specific Surface Glycoprotein CD28.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of T Cell Specific Surface Glycoprotein CD28 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of T Cell Specific Surface Glycoprotein CD28 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Lulizumab Pegol Table 2. Major Company of FR-104 Table 3. Major Company of FPT-155 Table 4. Major Company of Others Table 5. Global T Cell Specific Surface Glycoprotein CD28 Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global T Cell Specific Surface Glycoprotein CD28 Sales by Type (2021-2026) & (K Units) Table 7. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Type (2021-2026) Table 8. Global T Cell Specific Surface Glycoprotein CD28 Sales by Type (2021-2026) & (US$ Million) Table 9. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Type (2021-2026) Table 10. Global T Cell Specific Surface Glycoprotein CD28 Price by Type (2021-2026) & (US$/Unit) Table 11. Global T Cell Specific Surface Glycoprotein CD28 Sales by Type (2027-2032) & (K Units) Table 12. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Type (2027-2032) Table 13. Global T Cell Specific Surface Glycoprotein CD28 Sales by Type (2027-2032) & (US$ Million) Table 14. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Type (2027-2032) Table 15. Global T Cell Specific Surface Glycoprotein CD28 Price by Type (2027-2032) & (US$/Unit) Table 16. North America T Cell Specific Surface Glycoprotein CD28 Sales by Type (2021-2026) & (K Units) Table 17. North America T Cell Specific Surface Glycoprotein CD28 Sales by Type (2021-2026) & (US$ Million) Table 18. Europe T Cell Specific Surface Glycoprotein CD28 Sales by Type (2021-2026) & (K Units) Table 19. Europe T Cell Specific Surface Glycoprotein CD28 Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America T Cell Specific Surface Glycoprotein CD28 Sales by Type (2021-2026) & (K Units) Table 23. Latin America T Cell Specific Surface Glycoprotein CD28 Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales by Type (2021-2026) & (US$ Million) Table 26. T Cell Specific Surface Glycoprotein CD28 Industry Trends Table 27. T Cell Specific Surface Glycoprotein CD28 Industry Drivers Table 28. T Cell Specific Surface Glycoprotein CD28 Industry Opportunities and Challenges Table 29. T Cell Specific Surface Glycoprotein CD28 Industry Restraints Table 30. Global T Cell Specific Surface Glycoprotein CD28 Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Company (2021-2026) Table 32. Global T Cell Specific Surface Glycoprotein CD28 Sales by Company (2021-2026) & (K Units) Table 33. Global T Cell Specific Surface Glycoprotein CD28 Sales Share by Company (2021-2026) Table 34. Global T Cell Specific Surface Glycoprotein CD28 Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global T Cell Specific Surface Glycoprotein CD28 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global T Cell Specific Surface Glycoprotein CD28 Major Company Production Sites and Headquarters Table 37. Global T Cell Specific Surface Glycoprotein CD28 Company, Product Type & Application Table 38. Global T Cell Specific Surface Glycoprotein CD28 Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global T Cell Specific Surface Glycoprotein CD28 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global T Cell Specific Surface Glycoprotein CD28 Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global T Cell Specific Surface Glycoprotein CD28 Sales by Region (2021-2026) & (K Units) Table 43. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Region (2021-2026) Table 44. Global T Cell Specific Surface Glycoprotein CD28 Sales by Region (2021-2026) & (US$ Million) Table 45. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Region (2021-2026) Table 46. Global T Cell Specific Surface Glycoprotein CD28 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global T Cell Specific Surface Glycoprotein CD28 Sales by Region (2027-2032) & (K Units) Table 48. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Region (2027-2032) Table 49. Global T Cell Specific Surface Glycoprotein CD28 Sales by Region (2027-2032) & (US$ Million) Table 50. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Region (2027-2032) Table 51. Global T Cell Specific Surface Glycoprotein CD28 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global T Cell Specific Surface Glycoprotein CD28 Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global T Cell Specific Surface Glycoprotein CD28 Sales by Application (2021-2026) & (K Units) Table 54. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Application (2021-2026) Table 55. Global T Cell Specific Surface Glycoprotein CD28 Sales by Application (2021-2026) & (US$ Million) Table 56. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Application (2021-2026) Table 57. Global T Cell Specific Surface Glycoprotein CD28 Price by Application (2021-2026) & (US$/Unit) Table 58. Global T Cell Specific Surface Glycoprotein CD28 Sales by Application (2027-2032) & (K Units) Table 59. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Application (2027-2032) Table 60. Global T Cell Specific Surface Glycoprotein CD28 Sales by Application (2027-2032) & (US$ Million) Table 61. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Application (2027-2032) Table 62. Global T Cell Specific Surface Glycoprotein CD28 Price by Application (2027-2032) & (US$/Unit) Table 63. North America T Cell Specific Surface Glycoprotein CD28 Sales by Application (2021-2026) & (K Units) Table 64. North America T Cell Specific Surface Glycoprotein CD28 Sales by Application (2021-2026) & (US$ Million) Table 65. Europe T Cell Specific Surface Glycoprotein CD28 Sales by Application (2021-2026) & (K Units) Table 66. Europe T Cell Specific Surface Glycoprotein CD28 Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America T Cell Specific Surface Glycoprotein CD28 Sales by Application (2021-2026) & (K Units) Table 70. Latin America T Cell Specific Surface Glycoprotein CD28 Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales by Application (2021-2026) & (US$ Million) Table 73. Johnson & Johnson Company Information Table 74. Johnson & Johnson Business Overview Table 75. Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Product Portfolio Table 77. Johnson & Johnson Recent Development Table 78. TheraMAB LLC Company Information Table 79. TheraMAB LLC Business Overview Table 80. TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Product Portfolio Table 82. TheraMAB LLC Recent Development Table 83. Five Prime Therapeutics Inc Company Information Table 84. Five Prime Therapeutics Inc Business Overview Table 85. Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Product Portfolio Table 87. Five Prime Therapeutics Inc Recent Development Table 88. Bristol-Myers Squibb Co Company Information Table 89. Bristol-Myers Squibb Co Business Overview Table 90. Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Product Portfolio Table 92. Bristol-Myers Squibb Co Recent Development Table 93. Atox Bio Ltd Company Information Table 94. Atox Bio Ltd Business Overview Table 95. Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Product Portfolio Table 97. Atox Bio Ltd Recent Development Table 98. North America T Cell Specific Surface Glycoprotein CD28 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 99. North America T Cell Specific Surface Glycoprotein CD28 Sales by Country (2021-2026) & (K Units) Table 100. North America T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Country (2021-2026) Table 101. North America T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Country (2027-2032) & (K Units) Table 102. North America T Cell Specific Surface Glycoprotein CD28 Sales Market Share Forecast by Country (2027-2032) Table 103. North America T Cell Specific Surface Glycoprotein CD28 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. North America T Cell Specific Surface Glycoprotein CD28 Market Size by Country (2021-2026) & (US$ Million) Table 105. North America T Cell Specific Surface Glycoprotein CD28 Market Share by Country (2021-2026) Table 106. North America T Cell Specific Surface Glycoprotein CD28 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. North America T Cell Specific Surface Glycoprotein CD28 Market Share Forecast by Country (2027-2032) Table 108. Europe T Cell Specific Surface Glycoprotein CD28 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 109. Europe T Cell Specific Surface Glycoprotein CD28 Sales by Country (2021-2026) & (K Units) Table 110. Europe T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Country (2021-2026) Table 111. Europe T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Country (2027-2032) & (K Units) Table 112. Europe T Cell Specific Surface Glycoprotein CD28 Sales Market Share Forecast by Country (2027-2032) Table 113. Europe T Cell Specific Surface Glycoprotein CD28 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Europe T Cell Specific Surface Glycoprotein CD28 Market Size by Country (2021-2026) & (US$ Million) Table 115. Europe T Cell Specific Surface Glycoprotein CD28 Market Share by Country (2021-2026) Table 116. Europe T Cell Specific Surface Glycoprotein CD28 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Europe T Cell Specific Surface Glycoprotein CD28 Market Share Forecast by Country (2027-2032) Table 118. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 119. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales by Country (2021-2026) & (K Units) Table 120. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Country (2021-2026) Table 121. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Country (2027-2032) & (K Units) Table 122. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Market Size by Country (2021-2026) & (US$ Million) Table 125. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Market Share by Country (2021-2026) Table 126. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Market Share Forecast by Country (2027-2032) Table 128. Latin America T Cell Specific Surface Glycoprotein CD28 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 129. Latin America T Cell Specific Surface Glycoprotein CD28 Sales by Country (2021-2026) & (K Units) Table 130. Latin America T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Country (2021-2026) Table 131. Latin America T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Country (2027-2032) & (K Units) Table 132. Latin America T Cell Specific Surface Glycoprotein CD28 Sales Market Share Forecast by Country (2027-2032) Table 133. Latin America T Cell Specific Surface Glycoprotein CD28 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America T Cell Specific Surface Glycoprotein CD28 Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America T Cell Specific Surface Glycoprotein CD28 Market Share by Country (2021-2026) Table 136. Latin America T Cell Specific Surface Glycoprotein CD28 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America T Cell Specific Surface Glycoprotein CD28 Market Share Forecast by Country (2027-2032) Table 138. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 139. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales by Country (2021-2026) & (K Units) Table 140. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Country (2021-2026) Table 141. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Country (2027-2032) & (K Units) Table 142. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Market Share by Country (2021-2026) Table 146. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Market Share Forecast by Country (2027-2032) Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. T Cell Specific Surface Glycoprotein CD28 Distributors List Table 151. T Cell Specific Surface Glycoprotein CD28 Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. T Cell Specific Surface Glycoprotein CD28 Image Figure 2. Global T Cell Specific Surface Glycoprotein CD28 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global T Cell Specific Surface Glycoprotein CD28 Market Size (2021-2032) & (US$ Million) Figure 4. Global T Cell Specific Surface Glycoprotein CD28 Sales (2021-2032) & (K Units) Figure 5. Lulizumab Pegol Image Figure 6. Global Lulizumab Pegol Sales YoY Growth (2021-2032) & (K Units) Figure 7. FR-104 Image Figure 8. Global FR-104 Sales YoY Growth (2021-2032) & (K Units) Figure 9. FPT-155 Image Figure 10. Global FPT-155 Sales YoY Growth (2021-2032) & (K Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global T Cell Specific Surface Glycoprotein CD28 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global T Cell Specific Surface Glycoprotein CD28 Market Share by Type 2025 VS 2032 Figure 15. North America T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Type in 2025 Figure 16. North America T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Type in 2025 Figure 17. Europe T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Type in 2025 Figure 18. Europe T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Type in 2025 Figure 21. Latin America T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Type in 2025 Figure 22. Latin America T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 T Cell Specific Surface Glycoprotein CD28 Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Plaque Psoriasis Image Figure 28. Global Plaque Psoriasis Sales YoY Growth (2021-2032) & (K Units) Figure 29. Acute Renal Failure(ARF) Image Figure 30. Global Acute Renal Failure(ARF) Sales YoY Growth (2021-2032) & (K Units) Figure 31. Solid Tumor Image Figure 32. Global Solid Tumor Sales YoY Growth (2021-2032) & (K Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global T Cell Specific Surface Glycoprotein CD28 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global T Cell Specific Surface Glycoprotein CD28 Market Share by Application 2025 VS 2032 Figure 37. North America T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Application in 2025 Figure 38. North America T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Application in 2025 Figure 39. Europe T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Application in 2025 Figure 40. Europe T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Application in 2025 Figure 43. Latin America T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Application in 2025 Figure 44. Latin America T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales Market Share in Value by Application in 2025 Figure 47. North America T Cell Specific Surface Glycoprotein CD28 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America T Cell Specific Surface Glycoprotein CD28 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America T Cell Specific Surface Glycoprotein CD28 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America T Cell Specific Surface Glycoprotein CD28 Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe T Cell Specific Surface Glycoprotein CD28 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe T Cell Specific Surface Glycoprotein CD28 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe T Cell Specific Surface Glycoprotein CD28 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe T Cell Specific Surface Glycoprotein CD28 Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America T Cell Specific Surface Glycoprotein CD28 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America T Cell Specific Surface Glycoprotein CD28 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America T Cell Specific Surface Glycoprotein CD28 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America T Cell Specific Surface Glycoprotein CD28 Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. T Cell Specific Surface Glycoprotein CD28 Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. T Cell Specific Surface Glycoprotein CD28 Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Lulizumab Pegol
  • FR-104
  • FPT-155
  • Others
Applications
  • Plaque Psoriasis
  • Acute Renal Failure(ARF)
  • Solid Tumor
  • Others
Companies covered
  • Johnson & Johnson
  • TheraMAB LLC
  • Five Prime Therapeutics Inc
  • Bristol-Myers Squibb Co
  • Atox Bio Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global T Cell Specific Surface Glycoprotein CD28 Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global T Cell Specific Surface Glycoprotein CD28 Sales Estimates and Forecasts (2021-2032)
  5. 1.3 T Cell Specific Surface Glycoprotein CD28 Market by Type
  6. 1.3.1 Lulizumab Pegol
  7. 1.3.2 FR-104
  8. 1.3.3 FPT-155
  9. 1.3.4 Others
  10. 1.4 Global T Cell Specific Surface Glycoprotein CD28 Market Size by Type
  11. 1.4.1 Global T Cell Specific Surface Glycoprotein CD28 Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global T Cell Specific Surface Glycoprotein CD28 Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global T Cell Specific Surface Glycoprotein CD28 Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America T Cell Specific Surface Glycoprotein CD28 Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe T Cell Specific Surface Glycoprotein CD28 Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America T Cell Specific Surface Glycoprotein CD28 Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 T Cell Specific Surface Glycoprotein CD28 Industry Trends
  2. 2.2 T Cell Specific Surface Glycoprotein CD28 Industry Drivers
  3. 2.3 T Cell Specific Surface Glycoprotein CD28 Industry Opportunities and Challenges
  4. 2.4 T Cell Specific Surface Glycoprotein CD28 Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by T Cell Specific Surface Glycoprotein CD28 Revenue (2021-2026)
  2. 3.2 Global Top Players by T Cell Specific Surface Glycoprotein CD28 Sales (2021-2026)
  3. 3.3 Global Top Players by T Cell Specific Surface Glycoprotein CD28 Price (2021-2026)
  4. 3.4 Global T Cell Specific Surface Glycoprotein CD28 Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global T Cell Specific Surface Glycoprotein CD28 Major Company Production Sites & Headquarters
  6. 3.6 Global T Cell Specific Surface Glycoprotein CD28 Company, Product Type & Application
  7. 3.7 Global T Cell Specific Surface Glycoprotein CD28 Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global T Cell Specific Surface Glycoprotein CD28 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 T Cell Specific Surface Glycoprotein CD28 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 T Cell Specific Surface Glycoprotein CD28 Tier 1, Tier 2, and Tier 3
4 T Cell Specific Surface Glycoprotein CD28 Regional Status and Outlook
  1. 4.1 Global T Cell Specific Surface Glycoprotein CD28 Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global T Cell Specific Surface Glycoprotein CD28 Historic Market Size by Region
  3. 4.2.1 Global T Cell Specific Surface Glycoprotein CD28 Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global T Cell Specific Surface Glycoprotein CD28 Sales in Value by Region (2021-2026)
  5. 4.2.3 Global T Cell Specific Surface Glycoprotein CD28 Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global T Cell Specific Surface Glycoprotein CD28 Forecasted Market Size by Region
  7. 4.3.1 Global T Cell Specific Surface Glycoprotein CD28 Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global T Cell Specific Surface Glycoprotein CD28 Sales in Value by Region (2027-2032)
  9. 4.3.3 Global T Cell Specific Surface Glycoprotein CD28 Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 T Cell Specific Surface Glycoprotein CD28 by Application
  1. 5.1 T Cell Specific Surface Glycoprotein CD28 Market by Application
  2. 5.1.1 Plaque Psoriasis
  3. 5.1.2 Acute Renal Failure(ARF)
  4. 5.1.3 Solid Tumor
  5. 5.1.4 Others
  6. 5.2 Global T Cell Specific Surface Glycoprotein CD28 Market Size by Application
  7. 5.2.1 Global T Cell Specific Surface Glycoprotein CD28 Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global T Cell Specific Surface Glycoprotein CD28 Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global T Cell Specific Surface Glycoprotein CD28 Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America T Cell Specific Surface Glycoprotein CD28 Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe T Cell Specific Surface Glycoprotein CD28 Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America T Cell Specific Surface Glycoprotein CD28 Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Johnson & Johnson
  2. 6.1.1 Johnson & Johnson Company Information
  3. 6.1.2 Johnson & Johnson Business Overview
  4. 6.1.3 Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Product Portfolio
  6. 6.1.5 Johnson & Johnson Recent Developments
  7. 6.2 TheraMAB LLC
  8. 6.2.1 TheraMAB LLC Company Information
  9. 6.2.2 TheraMAB LLC Business Overview
  10. 6.2.3 TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Product Portfolio
  12. 6.2.5 TheraMAB LLC Recent Developments
  13. 6.3 Five Prime Therapeutics Inc
  14. 6.3.1 Five Prime Therapeutics Inc Company Information
  15. 6.3.2 Five Prime Therapeutics Inc Business Overview
  16. 6.3.3 Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Product Portfolio
  18. 6.3.5 Five Prime Therapeutics Inc Recent Developments
  19. 6.4 Bristol-Myers Squibb Co
  20. 6.4.1 Bristol-Myers Squibb Co Company Information
  21. 6.4.2 Bristol-Myers Squibb Co Business Overview
  22. 6.4.3 Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Product Portfolio
  24. 6.4.5 Bristol-Myers Squibb Co Recent Developments
  25. 6.5 Atox Bio Ltd
  26. 6.5.1 Atox Bio Ltd Company Information
  27. 6.5.2 Atox Bio Ltd Business Overview
  28. 6.5.3 Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Product Portfolio
  30. 6.5.5 Atox Bio Ltd Recent Developments
7 North America by Country
  1. 7.1 North America T Cell Specific Surface Glycoprotein CD28 Sales by Country
  2. 7.1.1 North America T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America T Cell Specific Surface Glycoprotein CD28 Sales by Country (2021-2026)
  4. 7.1.3 North America T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Country (2027-2032)
  5. 7.2 North America T Cell Specific Surface Glycoprotein CD28 Market Size by Country
  6. 7.2.1 North America T Cell Specific Surface Glycoprotein CD28 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America T Cell Specific Surface Glycoprotein CD28 Market Size by Country (2021-2026)
  8. 7.2.3 North America T Cell Specific Surface Glycoprotein CD28 Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe T Cell Specific Surface Glycoprotein CD28 Sales by Country
  2. 8.1.1 Europe T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe T Cell Specific Surface Glycoprotein CD28 Sales by Country (2021-2026)
  4. 8.1.3 Europe T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Country (2027-2032)
  5. 8.2 Europe T Cell Specific Surface Glycoprotein CD28 Market Size by Country
  6. 8.2.1 Europe T Cell Specific Surface Glycoprotein CD28 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe T Cell Specific Surface Glycoprotein CD28 Market Size by Country (2021-2026)
  8. 8.2.3 Europe T Cell Specific Surface Glycoprotein CD28 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales by Country
  2. 9.1.1 Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Market Size by Country
  6. 9.2.1 Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America T Cell Specific Surface Glycoprotein CD28 Sales by Country
  2. 10.1.1 South America T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America T Cell Specific Surface Glycoprotein CD28 Sales by Country (2021-2026)
  4. 10.1.3 South America T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Country (2027-2032)
  5. 10.2 South America T Cell Specific Surface Glycoprotein CD28 Market Size by Country
  6. 10.2.1 South America T Cell Specific Surface Glycoprotein CD28 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America T Cell Specific Surface Glycoprotein CD28 Market Size by Country (2021-2026)
  8. 10.2.3 South America T Cell Specific Surface Glycoprotein CD28 Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales by Country
  2. 11.1.1 Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Market Size by Country
  6. 11.2.1 Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 T Cell Specific Surface Glycoprotein CD28 Value Chain Analysis
  2. 12.1.1 T Cell Specific Surface Glycoprotein CD28 Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 T Cell Specific Surface Glycoprotein CD28 Production Mode & Process
  7. 12.2 T Cell Specific Surface Glycoprotein CD28 Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 T Cell Specific Surface Glycoprotein CD28 Distributors
  10. 12.2.3 T Cell Specific Surface Glycoprotein CD28 Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst